| Question | Answer |
| Regulation of blood glucose levels | Utilised by all body tissues
Brain especially sensitive to low glucose
Stress response hormones increase blood glucose e.g. fight or flight, cortisol
Insulin is the only hormone which decreases blood glucose |
| Anatomy of the pancreas | Derived from the developing endoderm of the foregut
Islets make up 1% of pancreatic mass
Islets distinguishable in human embryo from 12th week
Surrounded by lots of vessels so is hard to operate on
Behind the stomach |
| Innervation | Innervated by both sympathetic and parasympathetic nerves
Via myenteric plexus |
| Islets of Langerhans | Clusters of 1000 endocrine cells
1 million islets in a human
Different islet endocrine types; alpha (glucagon), beta (insulin), delta (somatostatin), PP-cells (pancreatic polypeptide) and epsilon (Ghrelin) |
| Insulin | Gene located on chromosome 11
Expressed as preproinsulin and processed to make mature insulin
Cleavage of C-peptide occurs in the golgi
Mature insulin stored in secretory vesicles - 8fg per granule
10000 granules per beta cell |
| Glucose sensing in beta cells | Increase in glucose moving in through GLUT1/2
Converted to ATP through oxidative metabolism
ATP blocks potassium ATP channels
Cell depolarises opening CVGGs
Leads to exocytosis of vesicles |
| Biphasic secretion of insulin | Initial rapid rise in insulin conc following glucose consumption
Continues to increase over the next 2 hours as glucose moves into cells |
| Insulin action | Stimulated by increased blood glucose
Inhibits release of glucose from the liver
Promotes uptake of glucose into muscle and fat |
| Factors affecting insulin secretion | Increased blood glucose
PSNS
Amino acids
Fatty acids
Glucagon
Gastrointestinal hormones
SNS and Somatostatin inhibit |
| Insulin receptor | Tyrosine kinase
Dimerises on activation and auto phosphorylates
Inserts GLUT4 into membrane
Enzymes involved in metabolic pathways are activated or inactivated |
| Main actions of insulin | Carbohydrate metabolism - GLUT4, glycolysis, glycogenesis, inhibits gluconeogenesis and glycogenolysis
Protein metabolism - stimulates AA uptake and protein synthesis
Lipid metabolism - Stimulates lipogenesis and inhibits lioplysis |
| Action of insulin on K | Insulin shifts potassium into cells by activating the sodium hydrogen transporter
Promotes sodium entry
Activates NA K pump
Causes electrogenic influx of K |
| Glucose transporters | GLUT1 - plasma membrane of all cells - glucose, galactose and mannose
GLUT2 - intestine, kidney etc - glucose and fructose
GLUT3 - everywhere - glucose
GLUT4 - muscle - glucose
GLUT5 - gut - fructose |
| Sodium coupled glucose transporters | SGLT1 - intestine and kidneys = (2 NA for 1 glucose)
SGLT2 kidney - (1 Na for 1 glucose) |
| Incretin hormones | GLP-1 and GIP
Enhance insulin secretion - more insulin when glucose given orally than IV
Appetite regulation
Peripheral insulin sensitivity
Secreted from small intestine |
| Healthy vs diseased beta cells | Healthy - incretin hormones are responsible for glucose secretion
Diseased - K atp channels responsible for glucose secretion
GIP pathway not active in diabetics - explains why metformin has no effect on healthy cells |
| Release of incretin hormones | Stimulated by glucose, AAs and FAs
K cells are glucose dependant and secrete GIP
L cells are nutrient regulated and secrete GLP1, peptide YY and oxyntomodulin |
| How does GLP1 lower glucose | Inhibits glucagon secretion
Stimulates insulin secretion
Decreases appetite
Inhibits gastric emptying |
| Production and degradation of GLP1 | Glucagon - pro-glucagon - GLP1 by prohormone convertase 1/3
secreted
GLP1 - small peptides - amino acids by dipeptidyl peptidase IV |
| Alpha cells and glucagon | Highly redundant
Preproglucagon processed into a large number of active proteins
Converted to hormone, glucagon etc
Cam mobilise glucose or promote glucose uptake
Different processing gives different role |
| Factors affecting glucagon synthesis | Decreased blood glucose
SNS
AAs
GI hormones
inhibited by somatostatin and insulin |
| Glucagon receptors | Gas coupled GPCRs
Mostly expressed on hepatocytes and adipocytes
Mechanism of action involves adenylate cyclase activity and increase in cAMP
Affects both gene expression and post translational modifications |
| Somatostatin | Inhibitory polypeptide found in brain, GI tract and islets
Cleaved from prosomatostatin - 14aas in brain and 28 aa in islets
Pancreatic inhibitor of insulin and glucagon secretion - brake on islet cell activity
Inhibitory Gas GPCR |
| Diabetes mellitus | Urine output increases
Urine contains raised amounts of glucose
Caused by lack of glucose
Type 1 - lack of insulin
Type 2 - resistance to insulin and collapsing b cell function
More than one cause of type 2 |
| Normal blood glucose | Normal fasting plasma glucose - 3.5-5.5 mM
Considered hypoglycaemic if <4 mM
Diagnosis of diabetes if > 7 mM
Normal individuals clear glucose in 2 hours diabetic >11.1 mM after 2 hours |
| Causes of diabetes mellitus | Type 1 - immune destruction of B cells
Neonatal - mutations in K atp channels
Type 2 - impaired b cell function and defective insulin signalling in metabolic syndrome
Gestational diabetes
Maturity onset diabetes of young people - mutations in 6 genes |
| Type 1 Diabetes | Insulin dependent
Immune destruction of beta cells
Complete lack of insulin signals starvation increasing gluconeogenesis and glycolysis
Ketogenesis is upregulated
Peak incidence 12-14
Genetic and environment play a role |
| Type 2 diabetes | Non-insulin dependent
Adult onset and associated with diabetes
Combo of insulin resistance and b cell failure
No ketogenesis but hyperglycaemia seen
Presents as polyuria and polydipsia
Can be non-symptomatic at <11.1 mM |
| Complications of diabetes | Gangrenous foot - poor blood and nerve supply
Neuropathy in retina leading to blindness
Kidney damage - primary cause of death
Albumin detected in urine due to podocyte damage
Results from glycosylation of proteins in high plasma glucose |
| Glycosylated haemoglobin | A form of haemoglobin measured to identify the average plasma glucose concentration over prolonged periods of time
HbA1c formed in non-enzymatic glycosylation on exposure to plasma glucose
Marker of high glucose over a long period |
| Glycation | A result of covalent bonding of a protein or lipid with sugars like fructose and glucose
A haphazard process that impairs function of targets |